Feedback

Clinical trials of Russian anti-Covid-19 vaccine to start in Belarus in October

Source : 112 Ukraine

Belarus became the first country where the clinical trials of the Russian vaccine started.
20:53, 29 September 2020

Open source

On October 1, the testing of the Russian vaccine against Covid-19 – Sputnik-V – will start on Belarusian volunteers, as the Russian Direct Investment Fund reported.

“On October 1, in the Republic of Belarus, the vaccination of volunteers will start within the holding of a double-blind random placebo-controlled study of Sputnik-V vaccine,” the message said.

Related: Covid-19 vaccine alone not to change situation drastically, - UN Chief

100 Belarusians will participate in the clinical trial of the medicine developed by N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology. The clinical trials will take place at eight medical establishments chosen as the research centers. Two Belarusian clinics have already received the first batches of the Sputnik-V vaccine.

Belarus became the first country where the clinical trials of the Russian vaccine started.

Related: Two million people likely to die before Covid-19 vaccine mass release, - World Health Organization

On August 11, President of Russia Vladimir Putin reported that the first vaccine against coronavirus was registered in Russia.

The vaccine would be produced by N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology and the Russian Binnopharm Company. According to Murashko, finalizing takes place of the technical regulations for scaling of production at the number of Russian productions.

Related: WHO plans to produce at least 2 billion doses of coronavirus vaccine by the end of 2021

However, the WHO doubted the safety of the Russian vaccine against Covid-19.

Earlier, the Health Ministry of Russia released to the civil circulation the first batch of Sputnik V vaccine against the coronavirus.

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more